CAREMARK SIGNS DISEASE MANAGEMENT ALLIANCES WITH PFIZER, RHONE-POULENC RORER AND THIRD COMPANY; DESIGN OF RISK SHARING PROGRAMS ALSO IN AGREEMENT
Executive Summary
Caremark alliances with Pfizer, Rhone-Poulenc Rorer and a third unidentified company will include development of programs to improve the use of pharmaceuticals for treating diseases such as asthma, depression, hypertension, heart disease, diabetes and HIV/AIDS. The third partner is generally believed to be Bristol- Myers Squibb, which often has been identified as being in strategic alliance negotiations.